Evidence map›Paper›PMID 36447117›Full record

ReviewDermatology and therapy2023

Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review.

Sophia Ly, Kanika Kamal, Priya Manjaly, John S Barbieri, Arash Mostaghimi

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Dermatology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-Short version.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Guideline
  2. Review
  3. Review
  4. Acne tarda: Recommendations for classification, treatment and care as a result of an expert discussion.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Review
  5. Safety and effectiveness of topical dapsone in acne treatment: A review.Journal of family medicine and primary care · 2026
    Review
  6. Breast and Nipple Dermatoses During Lactation.The Australasian journal of dermatology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sophia LyUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.
Kanika KamalHarvard Medical School, Boston, MA, USA.
Priya ManjalyBoston University School of Medicine, Boston, MA, USA.
John S BarbieriHarvard Medical School, Boston, MA, USA.
Arash MostaghimiHarvard Medical School, Boston, MA, USA. amostaghimi@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-6084-5617
Brigham and Women's Hospital · US

Funding

Applying Item Response Theory to Improve Patient Reported Outcome Use in Dermatology Clinical PracticeK23AR078930 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI John Barbieri · 2022 to 2026
$867k
NIAMS NIH HHS K23 AR078930
6 · The paper itself

Abstract

Acne vulgaris frequently affects women during pregnancy and lactation. Hormonal and physiologic changes in pregnancy contribute to the pathogenesis of acne during the various phases of pregnancy. Several effective acne treatments commonly prescribed in the general population are contraindicated during pregnancy or lactation. There is a lack of guidelines and updated resources on acne management in these populations. In this narrative review, we summarize existing evidence on the safety and efficacy of acne treatments during pregnancy and breastfeeding. Acne management in pregnancy and lactation should follow a stepwise approach based on severity to minimize risk. Topical therapies, such as benzoyl peroxide, azelaic acid, or keratolytics, can be used to treat mild-to-moderate disease. Moderate-to-severe acne may require systemic treatments, including penicillin, amoxicillin, cephalexin, and erythromycin, with special consideration for trimester-specific teratogenicity of medications and relevant medical history of the mother and infant. For refractory cases, oral or intralesional corticosteroids as well as laser and light therapies may be considered. This review provides an updated reference to aid patient-physician decision-making on acne management in these special populations.

Indexed as

Acne vulgarisLactationManagementPregnancyTeratogen

Identifiers

PMID36447117
PMCPMC9823189
OpenAlexW4310459133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.